Potential Long-term Effects of MDMA on the Basal Ganglia–Thalamocortical Circuit: A Proton MR Spectroscopy and Diffusion-Tensor Imaging Study
Hua-Shan Liu, Ming‐Chung Chou, Hsiao‐Wen Chung, Nai‐Yu Cho, Shih-Wei Chiang, Chao-Ying Wang, Hung‐Wen Kao, Guo-Shu Huang, Cheng‐Yu Chen
Radiology June 3, 2011 DOI: 10.1148/radiol.11101918 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 64 |
| Population | Long-term (>1 year) MDMA users and healthy control subjects |
| Measures | proton MR spectroscopy, diffusion-tensor MR imaging |
| Topics | MDMA |
| Citations | 20 |
| Key findings | MDMA users had significantly higher myo-inositol levels in the basal ganglia (left: 4.55 vs 3.25 mmol/L; right: 4.48 vs 3.31 mmol/L) and increased fractional anisotropy in the thalami, suggesting glial response to serotonergic degeneration and altered basal ganglia-thalamocortical function. |
Abstract
Purpose: To investigate the effects of 3,4-methylenedioxymethamphetamine (MDMA, commonly known as "ecstasy") on the alterations of brain metabolites and anatomic tissue integrity related to the function of the basal ganglia-thalamocortical circuit by using proton magnetic resonance (MR) spectroscopy and diffusion-tensor MR imaging.
Materials and Methods: This study was approved by a local institutional review board, and written informed consent was obtained from all subjects. Thirty-one long-term (>1 year) MDMA users and 33 healthy subjects were enrolled. Proton MR spectroscopy from the middle frontal cortex and bilateral basal ganglia and whole-brain diffusion-tensor MR imaging were performed with a 3.0-T system. Absolute concentrations of metabolites were computed, and diffusion-tensor data were registered to the International Consortium for Brain Mapping template to facilitate voxel-based group comparison.
Results: The mean myo-inositol level in the basal ganglia of MDMA users (left: 4.55 mmol/L ± 2.01 [standard deviation], right: 4.48 mmol/L ± 1.33) was significantly higher than that in control subjects (left: 3.25 mmol/L ± 1.30, right: 3.31 mmol/L ± 1.19) (P < .001). Cumulative lifetime MDMA dose showed a positive correlation with the levels of choline-containing compounds (Cho) in the right basal ganglia (r = 0.47, P = .02). MDMA users also showed a significant increase in fractional anisotropy (FA) in the bilateral thalami and significant changes in water diffusion in several regions related to the basal ganglia-thalamocortical circuit as compared with control subjects (P < .05; cluster size, >50 voxels).
Conclusion: Increased myo-inositol and Cho concentrations in the basal ganglia of MDMA users are suggestive of glial response to degenerating serotonergic functions. The abnormal metabolic changes in the basal ganglia may consequently affect the inhibitory effect of the basal ganglia to the thalamus, as suggested by the increased FA in the thalamus and abnormal changes in water diffusion in the corresponding basal ganglia-thalamocortical circuit.
Comparable studies
Other observational and cohort studies on MDMA, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Subjective Reports of the Effects of MDMA in a Clinical Setting Individuals who took MDMA in a clinical setting | 1986 | Observational study | |
| Memory impairment in abstinent MDMA ("Ecstasy") users Abstinent MDMA users | 1998 | Observational cohort | |
| Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people | 2000 | Observational | |
| The Psychological and Physiological Effects of MDMA on Normal Volunteers Older, more educated, drug-experienced individuals | 1986 | Observational cohort | |
| Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits Young people who were regular or novice MDMA users, or non-users | 1998 | Observational cohort | n = 30 |
Citations in the library
Cited by 4
- Neuroimaging of chronic MDMA (“ecstasy”) effects: A meta-analysis Neuroscience & Biobehavioral Reviews November 12, 2018
- Brain dysfunctions and neurotoxicity induced by psychostimulants in experimental models and humans: an overview of recent findings Neural Regeneration Research February 22, 2024
- White matter alterations in chronic MDMA use: Evidence from diffusion tensor imaging and neurofilament light chain blood levels NeuroImage: Clinical September 19, 2022
- Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex. The International Journal of Neuropsychopharmacology June 1, 2023
Cites 7
- Cerebral1H MRS alterations in recreational 3,4-methylenedioxymethamphetamine (MDMA, ?ecstasy?) users Journal of Magnetic Resonance Imaging October 1, 1999
- Diffusion Tensor Imaging in MDMA Users and Controls: Association with Decision Making The American Journal of Drug and Alcohol Abuse 2007
- Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users. Psychiatry Research June 18, 2007
- Neuroimaging research in human MDMA users: a review. Psychopharmacology January 2007
- Functional MRI study of working memory in MDMA users. Psychopharmacology December 2004
and 2 more in the library